Abstract. Somatostatin, pancreatic polypeptide (PP) 
pigs. After stimulation of insulin release with glucose and arginine, respectively, a prompt decrease in PP levels was found in pancreatic venous blood. Somatostatin declined after glucose administration but was unaffected by arginine. The changes in PP and somatostatin levels were not evident in systemic blood. The present results emphasize the advantage of selective sampling of pancreatic venous blood in studies on the possible interactions between pancreatic hormones. The marked decrease in PP seen after stimulation of insulin release in the present study, indicates that PP should be included together with somatostatin in further studies on pancreatic hormonal interplay.
As a contrast to the other known pancreatic hor¬ mones, pancreatic polypeptide (PP) has not been demonstrated to be implicated in the regulation of intermediary metabolism. However, PP secretion can be provoked by insulin-induced hypoglycaemia most likely via vagal mechanisms (Adrian et al. 1977; Marco et al. 1978) and substantial amounts of PP is released into the blood as a response to food ingestion (Adrian et al. 1976; Schwartz et al. 1976 ). Therefore PP has been discussed as a com¬ ponent of the entero-pancreatic endocrine axis.
RIA methods for the determination of plasma levels of somatostatin-like immunoreactivity (SLI) (Arimura et al. 1978; Berelowitz et Tyr-1-somatostatin (Beckman, Geneva) was used for iodination with the lactoperoxidase method and synthetic somatostatin (Beckman, Geneva) was used for prepara¬ tion of standards.
The plasma level of PP was determined by a previously described radioimmunoassay (Larsson et al. 1976 ), modi¬ fied according to Wide (1969) The glucose injection resulted in a peak blood glucose concentration of 8.1 ±1.0 (mean ± se) mmol/1. Basal levels = 3.9 ± 1.2. The increase in insulin after glucose and the decrease in glucagon were evident both in pancreatic (Fig. 1) and in mixed venous blood (Fig. 2) (Fig. 2) . Arginine infusion was followed by an insignifi¬ cant increase in blood glucose concentration, which was 3.9 ± 0.8 mmol/1 before and 4.6 ± 1.6 mmol/1 5 min after the end of the arginine infusion. The level of insulin and glucagon increased significantly (Figs. 3 and 4) . The changes in somatostatin and PP levels in pancreatic venous blood were not as evi¬ dent after arginine infusion as after glucose injec¬ tion. However, a small decrease in PP was found with a single significant (P < 0.05) change at 10 min after beginning of the arginine infusion. The somatostatin level showed an apparent transient increase although this change was not significant (P < 0.05). In mixed venous blood the hormone changes were less evident (Fig. 4) .
Discussion
In studies of the endocrine balance in the gastroin¬ testinal tract the pig has been found to be very suitable as experimental animal (Hoist 1977) . The main reason for this is the similarities between human and porcine intestinal peptides and also obvious similarities in gastrointestinal physiology. Besides that it was found in the present study to be easy to sample blood from the pancreatic venous effluent. Repeated blood samples could be ob¬ tained and the blood flow showed no apparent change during the experimental situation selected.
The statistical spread around the means was greater for all hormones studied in pancreatic venous blood than in systemic blood which may be due to interindividual variation in the location of the catheter tip. This justifies the statistical evalua¬ tion of experimental data as percental changes from initial values during the experimental situa¬ tions studied.
A significant decrease in somatostatin immunoreactivity in pancreatic venous blood was noted after iv administration of glucose, and this decrease was evident throughout the observation period. Results concerning somatostatin response after glucose is partly contradictory to earlier reports both from studies with isolated perfused pancreas and from in vivo studies. In some studies glucose is considered as a potent somatostatin secretagogue Schauder et al. 1976; Patton et al. 1977 Concerning PP data higher basal levels were found in present investigation compared to earlier reported data (Schwartz et al. 1978 ) from the same species. Although confusing, this discrepancy could possibly be explained by differences in stan¬ dardisation of the methods used, since similar antiserum have been used in both studies. Concor¬ dant results of PP levels in uraemia (Hällgren et al. 1977 ) and after insulin-induced hypoglycaemia compared to other investigators (Schwartz et al. 1978; Collins et al. 1978) further supports the specificity of the PP radioimmunoassay used.
PP levels in pancreatic venous blood has not earlier been reported. There are, however, data from measurements in peripheral blood indicating that intravenous glucose is followed by a diminish¬ ed PP level (Marco et al. 1978; Sive et al. 1979 ). 
